HDAC Inhibitor Abrogates LTA-Induced PAI-1 Expression in Pleural Mesothelial Cells and Attenuates Experimental Pleural Fibrosis.

Chen, Wei-Lin; Chen, Mei-Chuan; Hsu, Shang-Fu; Hsiao, Shih-Hsin; Chung, Chi-Li

Chen, Wei-Lin; Chen, Mei-Chuan; Hsu, Shang-Fu; Hsiao, Shih-Hsin; Chung, Chi-Li.

Afiliação

Chen WL; Department of Nursing, MacKay Junior College of Medicine, Nursing, and Management, Taipei 112, Taiwan.
Chen MC; Division of Pulmonary Medicine, Department of Internal Medicine, Taipei Medical University Hospital, Taipei 110, Taiwan.
Hsu SF; Division of Pulmonary Medicine, Department of Internal Medicine, Taipei Medical University Hospital, Taipei 110, Taiwan.
Hsiao SH; Division of Pulmonary Medicine, Department of Internal Medicine, Taipei Medical University Hospital, Taipei 110, Taiwan.
Chung CL; Division of Pulmonary Medicine, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.

Pharmaceuticals (Basel) ; 14(6)2021 Jun 18.

Article em En | MEDLINE | ID: mdl-34207271

Palavras-chave

histone deacetylase inhibitor; lipoteichoic acid; plasminogen activator inhibitor-1; pleural fibrosis; pleural mesothelial cell; residual pleural thickening

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Pharmaceuticals (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Taiwan

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google